0

Journal Articles

in Adverse Drug Effects
 41-60 of 111 Articles
Original Investigation | 
Daniel M. Witt, PharmD, FCCP, BCPS; Thomas Delate, PhD; David A. Garcia, MD; et al.
Arch Intern Med. 2012;172(19):1484-1491. doi:10.1001/archinternmed.2012.4261.
INCLUDES: , Supplemental Content

Invited Commentary | 
Daniel J. Brotman, MD; Amir K. Jaffer, MD
Arch Intern Med. 2012;172(19):1492-1493. doi:10.1001/archinternmed.2012.4309.

Invited Commentary | 
Chee M. Chan, MD, MPH; Andrew F. Shorr, MD, MPH
Arch Intern Med. 2012;172(18):1375-1376. doi:10.1001/archinternmed.2012.3650.

Research Letters | 
Abeer Ahmad, MSc; Giel Nijpels, MD, PhD; Jacqueline M. Dekker, PhD; et al.
Arch Intern Med. 2012;172(17):1346-1347. doi:10.1001/archinternmed.2012.2816.

Original Investigation | 
Gary D. Friedman, MD, MS; Maryam M. Asgari, MD, MPH; E. Margaret Warton, MPH; et al.
Arch Intern Med. 2012;172(16):1246-1251. doi:10.1001/archinternmed.2012.2754.

Special Article | 
Neil A. Holtzman, MD, MPH
Arch Intern Med. 2012;172(15):1174-1177. doi:10.1001/archinternmed.2012.2204.

Commentary | 
Donald M. Marcus, MD; Arthur P. Grollman, MD
Arch Intern Med. 2012;172(13):1035-1036. doi:10.1001/archinternmed.2012.2687.

Original Investigation | 
Iskandar Idris, MD, FRCP, FRCP(Edin); Graham Warren, PhD; Richard Donnelly, MD, PhD
Arch Intern Med. 2012;172(13):1005-1011. doi:10.1001/archinternmed.2012.1938.

Invited Commentary | 
Sonal Singh, MD, MPH; Jodi B. Segal, MD, MPH
Arch Intern Med. 2012;172(13):1011-1013. doi:10.1001/archinternmed.2012.2461.

Research Letters | 
Pieter A. Cohen, MD
Arch Intern Med. 2012;172(13):1038-1039. doi:10.1001/archinternmed.2012.1677.

Original Investigation |  FREE
Raphael P. H. Meier, MD; Thomas V. Perneger, MD; Richard Stern, MD; et al.
Arch Intern Med. 2012;172(12):930-936. doi:10.1001/archinternmed.2012.1796.

Invited Commentary | 
Douglas C. Bauer, MD
Arch Intern Med. 2012;172(12):936-937. doi:10.1001/archinternmed.2012.1827.

Editor's Correspondence | 
Niki Katsiki, MSc, PhD, MD, FRSPH; Maciej Banach, MD, PhD, FAHA, FESC, FASA, FRSPH
Arch Intern Med. 2012;172(11):895-896. doi:10.1001/archinternmed.2012.1240.

Editor's Correspondence | 
Harold Zeliger, PhD
Arch Intern Med. 2012;172(11):896-897. doi:10.1001/archinternmed.2012.1243.

Editor's Correspondence | 
Arch Intern Med. 2012;172(9):747-748. doi:10.1001/archinternmed.2012.1297.

Research Letters |  FREE
Chung-Wah Siu, MD; Marie P. Wong, MD; Chung-Man Ho, MBBS; et al.
Arch Intern Med. 2012;172(6):516-517. doi:10.1001/archinternmed.2011.1681.

Editor's Correspondence | 
Mio Sakuma, MD, PhD, MPH; Takeshi Morimoto, MD, PhD, MPH
Arch Intern Med. 2011;171(21):1960-1961. doi:10.1001/archinternmed.2011.553.

Editor's Correspondence | 
Denis O’Mahony, MD, FRCPI; Hilary Jane Hamilton, MB, MRCPI; Paul F. Gallagher, PhD, MRCPI; et al.
Arch Intern Med. 2011;171(21):1960-1961. doi:10.1001/archinternmed.2011.554.

Invited Commentary | 
Jeffrey L. Schnipper, MD, MPH, FHM
Arch Intern Med. 2011;171(11):1019-1020. doi:10.1001/archinternmed.2011.220.

Original Investigation |  FREE
Hilary Hamilton, MB, MRCPI; Paul Gallagher, PhD, MRCPI; Cristin Ryan, PhD, MPSI; et al.
Arch Intern Med. 2011;171(11):1013-1019. doi:10.1001/archinternmed.2011.215.
INCLUDES: , Supplemental Content

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Surgery
Special Feature  | 
Image of the Month—Diagnosis

JAMA
Viewpoint  | 
Opioid Analgesics—Risky Drugs, Not Risky Patients
Deborah Dowell, MD, MPH; Hillary V. Kunins, MD, MPH, MS; Thomas A. Farley, MD, MPH
JAMA
Medical News and Perspectives  | 
Zolpidem-Related Surge in Emergency Department Visits
Mike Mitka, MSJ
JAMA
Viewpoint  | 
Advances in Regulatory Science at the Food and Drug Administration
Bruce M. Psaty, MD, PhD; Steven N. Goodman, MD, MHS, PhD; Alasdair Breckenridge, MD